-
The chemotherapeutic CX-5461 is extremely mutagenic and may increase cancer risk
Study
EGAS50000000023
-
Enhancing OSCC Prediction: The Prognostic Power of WPOI and Tumor Budding, and the Limited Impact of Molecular Resection Margins
Study
EGAS50000000074
-
Arcagen – thoracic malignancies
Study
EGAS50000000123
-
Developing somatic copy number and mutation calling tools for a bespoke sequencing platform
Study
EGAS00001007195
-
Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals
Study
EGAS50000000179
-
Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole genome sequencing with histopathological features
Study
EGAS00001007438
-
Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative
Study
phs002790
-
Idiosyncratic and generic single nuclei and spatial transcriptional patterns in papillary and anaplastic thyroid cancers
Study
EGAS00001007574
-
Heterogeneity and evolution of DNA mutation rates in microsatellite-stable colorectal cancer
Study
EGAS50000000284
-
Heterogeneity and evolution of DNA mutation rates in microsatellite-stable colorectal cancer
Dataset
EGAD50000000411